Mizuho Securities upgraded FibroGen (NASDAQ: FGEN) from Neutral to Buy with a price target of $61.00.Analyst Difel Yang comments "With ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE